Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Warning Label For Gadolinium Contrast Agents Gets US FDA Panel Backing

Sep 10 2017

• By Brenda Sandburg

FDAEntrance_1200x675

Related Content

Gadolinium Contrast Agent Retention In Brain May Require Label Warning

Sep 07 2017

Related Companies

Bayer AG

General Electric

Bracco S.p.A.

Guerbet Group

Siemens AG

Additional Topics

United States Minor Outlying Islands United States Advisory Committees Regulation FDA BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window